𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Beta-blockers in cirrhosis patients with refractory ascites

✍ Scribed by Robins, Anne; Bowden, Anne; Watson, William; Smith, Fiona; Gelson, William; Griffiths, William

Book ID
121186399
Publisher
John Wiley and Sons
Year
2014
Tongue
English
Weight
478 KB
Volume
59
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Beta-blockers in patients with cirrhosis
Beta-blockers in patients with cirrhosis and refractory ascites
✍ Albillos AgustΓ­n; Zamora Javier πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 296 KB πŸ‘ 2 views

We read with interest the reviews by Ghouri et al. 1 and Martinez et al. 2 Ghouri et al. analyzed the association of nonalcoholic fatty liver disease (NAFLD) with cardiovascular disease (CVD) and concluded that although a diagnosis of NAFLD should prompt diabetes screening, it is insufficient for co

Deleterious effects of beta-blockers on
Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites
✍ Mevlut Kurt πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 378 KB πŸ‘ 2 views

We read with great interest the article by Stepanova et al. 1 In this report from the United States with 10,582 eligible individuals (1.52% of whom were positive for hepatitis C virus [HCV] antibody [anti-HCV]), the rate of insurance coverage was significantly lower in patients with HCV infection (6

Deleterious effects of beta-blockers on
Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites
✍ Thomas SerstΓ©; Christian Melot; Claire Francoz; FranΓ§ois Durand; Pierre-Emmanuel πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 196 KB πŸ‘ 2 views

Beta-blockers may have a negative impact on survival in patients with cirrhosis and refractory ascites. The aim of this study was to evaluate the effect of the administration of beta-blockers on long-term survival in patients with cirrhosis and refractory ascites. We performed a single-center, obser

Is this really the end of beta-blockers
Is this really the end of beta-blockers in patients with cirrhosis and refractory ascites?
✍ Thierry Thevenot; Jean-Paul Cervoni; Elisabeth Monnet; Frances Sheppard; Vincent πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 387 KB πŸ‘ 2 views

We read with interest the study by Sola `et al., 1 who found that 39 patients (67%) had a very alarming decrease in their serum sodium levels ! 5 mEq/L during terlipressin treatment for acute variceal bleeding (AVB). We, however, feel that some of their observations may require a closer look by the